400 mg Teicoplanin Injection IP

Product Description

400 mg Teicoplanin Injection IP is a glycopeptide antibiotic used to treat serious bacterial infections caused by Gram-positive bacteria, including those resistant to other antibiotics like methicillin. It is effective in treating hospital-acquired pneumonia or ventilator-associated pneumonia caused by Gram-positive organisms. This is used to prevent or treat infections in patients with compromised immune systems (e.g., cancer, transplant, or HIV patients). Teicoplanin works by inhibiting bacterial cell wall synthesis, leading to bacterial death. 400 mg Teicoplanin Injection IP is effective against Staphylococcus aureus, Enterococcus faecalis and Streptococcus pneumoniae.

Product Type - Teicoplanin Injection IPP
Self Life - 1.5 To 2 Years 
Usage - Commercial